Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrey M. Petrov
Observed names:
A M Petrov,
A. M. Petrov,
A.M. Petrov,
Andrey Petrov,
А. М. Петров
Institution:
Institute of the Human Brain
Observed institutions:
Russian Academy of Sciences,
Institute of the Human Brain,
Russian Scientific Center of Radiology and Surgical Technologies,
Military Medical Academy
ORCID:
0000-0001-9648-5492
Observed ORCID:
0000-0001-9648-5492
OpenAlex ID:
A5090219209
Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy
2008
·
K. K. Mineev
, L. N. Prakhova
, et al.
·
Neuroscience and Behavioral Physiology
·
14
Time course of changes in the development of gait disorders in multiple sclerosis
2015
·
A. M. Petrov
, I. D. Stolyarov
, et al.
·
Neurology neuropsychiatry Psychosomatics
·
4
PDF
New possibilities for the therapy of secondary progressive multiple sclerosis
2019
·
A. M. Petrov
, E. V. Ivashkova
, et al.
·
Neurology neuropsychiatry Psychosomatics
·
3
PDF
Monoclonal Antibodies: Present and Future in the Treatment of Multiple Sclerosis (Based on the Proceedings of the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ECTRIMS)
2017
·
Marina V. Votintseva
, Andrey M. Petrov
, et al.
·
Annals of Clinical and Experimental Neurology
·
3
PDF
[Clinical and radiological (PET, MRI) correlations depending on disease progression in patients with multiple sclerosis].
2006
·
A G Il'ves
, L N Prakhova
, et al.
·
PubMed
·
3
Changes in the Parameters of Cellular Immunity in Patients with Right- and Left-Hemispheric Ischemic Strokes upon Transcranial Electromagnetic Stimulation
2002
·
E. V. Ivashkova
, A. M. Petrov
, et al.
·
Human Physiology
·
3
The correlation between motor and cognitive dysfunction in multiple sclerosis
2020
·
Konstantin K. Mineev
, Andrey M. Petrov
, et al.
·
Annals of Clinical and Experimental Neurology
·
2
PDF
Capabilities of positron emission tomography to study mechanisms of multiple sclerosis: own data and literature
2016
·
I. D. Stolyarov
, A. M. Petrov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
2
Clinical recommendations on the use of teriflunomide
2016
·
V. M. Alifirova
, K. Z. Bakhtiyarova
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
2
Assessment of biomechanical parameters of feet in patients with multiple sclerosis during walking
2023
·
A. D. Dorokhov
, E. V. Ivashkova
, et al.
·
Russian neurological Journal
·
1
PDF
Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic
2022
·
Andrey M. Petrov
, Marina V. Votintseva
, et al.
·
Annals of Clinical and Experimental Neurology
·
1
PDF
Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic
2021
·
E. V. Ivashkova
, A. M. Petrov
, et al.
·
Neurology neuropsychiatry Psychosomatics
·
1
Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis
2020
·
I.D. Stolyarov
, A.M. Petrov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
1
Ethical, clinical and scientific aspects of a research of medicinal drugs that alter progress of a multiple sclerosis at the current staging point
2019
·
Елена Ивашкова
, Марина Вотинцева
, et al.
·
Вестник Росздравнадзора
·
1
Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use
2015
·
I. D. Stolyarov
, A. M. Petrov
, et al.
·
Neurology neuropsychiatry Psychosomatics
·
1
PDF
Нейроиммунология: теоретические и клинические аспекты
2013
·
И. Д. Столяров
, А. М. Петров
, et al.
·
Human Physiology
·
1
[Brain atrophy and neurological impairment in patients with multiple sclerosis].
2009
·
L N Prakhova
, A G Il'ves
, et al.
·
PubMed
·
1
The Problem of Neuroimmunotherapy of Nervous Diseases
2002
·
I. D. Stolyarov
, A. M. Petrov
, et al.
·
Human Physiology
·
1
Spectroscopic analysis of metabolic profile in patients with relapsed multiple sclerosis
2022
·
Galina G. Shkilnyuk
, Andrey A. Bogdan
, et al.
·
Annals of Clinical and Experimental Neurology
PDF
Peripheral Blood Th17 Subsets in Patients With Multiple Sclerosis
2019
·
I V Kudryavtsev
, A M Petrov
, et al.
·
Medical academic journal
PDF
Potential of Positron Emission Tomography for Studies of the Mechanisms of Development of Multiple Sclerosis (published data and authors’ results)
2017
·
I. D. Stolyarov
, A. M. Petrov
, et al.
·
Neuroscience and Behavioral Physiology
Плацебо-контролируемые клинические исследования лекарственных средств у пациентов с рассеянным склерозом: этические аспекты
2014
·
М. В. Вотинцева
, Е. В. Ивашкова
, et al.
·
Вестник Росздравнадзора
Neuroimmunology: Theoretical and clinical aspects
2013
·
I. D. Stolyarov
, A. M. Petrov
, et al.
·
Human Physiology
Modern ethical aspects of clinical trials in patients with multiple sclerosis
2012
·
Е. В. Ивашкова
, А. М. Петров
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
[Pathogenetic treatment of multiple sclerosis: the present and the future].
2009
·
A N Boĭko
, I D Stoliarov
, et al.
·
PubMed
Show more works
View as search
Works count:
31
Citation count:
45
H-index:
3
I10-index:
1
Year
Topic
Type
